Suchergebnisse - "Xu, Binghe"

PubPharm (520)

61

Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer : A Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Yuan, P. | Kang, Y. | Ma, F. | +8

62

Advances in medical treatment of breast cancer in 2022

enthalten in: Cancer innovation | 2023

von Zhai, J. | Wu, Y. | Ma, F. | +2

63

Rationale and trial design of NATALEE : a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer

enthalten in: Therapeutic advances in medical oncology | 2023

von Slamon, D. | Fasching, P. | Hurvitz, S. | +22

ErratumIn: Ther Adv Med Oncol. 2023 Sep 29;15:17588359231201818. - PMID 37786535

64

Tumor senescence leads to poor survival and therapeutic resistance in human breast cancer

enthalten in: Frontiers in oncology | 2023

von Zhai, J. | Han, J. | Li, C. | +3

65

Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy

enthalten in: Journal of personalized medicine | 2023

von Li, Z. | Han, Y. | Wang, J. | +1

66

Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer : a retrospective multicenter study

enthalten in: Therapeutic advances in medical oncology | 2023

von Jiang, M. | Shao, B. | Wan, D. | +10

67

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer : updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Hurvitz, S. | Hegg, R. | Chung, W. | +27

CommentIn: Lancet. 2023 Jan 14;401(10371):80-81. - PMID 36495878

68

A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy

enthalten in: Journal of clinical medicine | 2023

von Chai, Y. | Zhao, F. | Ye, P. | +8

69

Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition)

in: Journal of the National Cancer Center | 2023

von Bu Hong | Fan Ying | Fan Zhaoqing | +29

70

A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple‐negative breast cancer who received at least two prior treatments

enthalten in: International Journal of Cancer | 2023

von Xu, B. | Ma, F. | Wang, T. | +15